Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,685	3,178	1,001	475	147	248
Market Cap Growth	75.35%	217.33%	110.88%	222.46%	-40.72%	77.14%
Enterprise Value	1,472	3,092	970	457	138	231
Last Close Price	13.27	24.97	7.95	3.77	1.28	2.48
PE Ratio	14.84	20.23	5442.54	-	-	-
Forward PE	18.72	32.20	19.55	-	-	-
PS Ratio	8.77	13.70	64.96	148.54	205.40	501.85
PB Ratio	7.74	15.49	24.08	12.10	6.09	17.94
P/TBV Ratio	12.41	15.49	24.08	12.10	6.09	17.94
P/FCF Ratio	14.11	17.19	279.73	-	-	-
P/OCF Ratio	22.75	17.18	278.25	-	-	-
EV/Sales Ratio	7.61	13.33	62.94	142.84	192.61	466.97
EV/EBITDA Ratio	9.49	15.52	-	-	-	-
EV/EBIT Ratio	9.49	15.52	-	-	-	-
EV/FCF Ratio	12.32	16.72	271.04	-	-	-
Asset Turnover	1.19	1.59	0.37	0.10	0.04	0.02
Quick Ratio	25.42	5.68	24.59	47.58	33.12	25.75
Current Ratio	25.42	5.78	25.77	49.87	33.12	25.75
Return on Equity (ROE)	75.51%	127.30%	0.46%	-24.57%	-48.32%	-56.16%
Return on Assets (ROA)	59.56%	85.52%	-1.10%	-15.83%	-27.98%	-33.73%
Return on Capital (ROIC)	62.43%	100.92%	-1.13%	-16.22%	-28.94%	-35.95%
Return on Capital Employed (ROCE)	70.79%	97.09%	-	-	-	-
Earnings Yield	6.96%	4.94%	0.02%	-1.64%	-6.24%	-4.35%
FCF Yield	7.09%	5.82%	0.36%	-2.10%	-5.49%	-4.72%
Buyback Yield / Dilution	-0.15%	-1.44%	-8.76%	-10.71%	-6.88%	-0.42%
Total Shareholder Return	-0.15%	-1.44%	-8.76%	-10.71%	-6.88%	-0.42%

Source: S&P Capital IQ. Standard template. Financial Sources.